23andMe Holding Co. (ME)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $19k
- May 2 · Routine
- Form 4 sales
- 27
- On record
- Form 144 notices
- 11
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleRoutineJan 25 2024
Sold 38,548 shares at $0.73 ($28k)
Hibbs Kathy L, Chief Administrative Officer
10b5-1 planSold 2.9% of holdings ($963k position)1.3M shares left1x usual sizeFollows a Form 144Filing
- 2 Form 4 saleRoutineFeb 15 +21 days
Sold 38,548 shares at $0.78 ($30k)
Hibbs Kathy L, Chief Administrative Officer
10b5-1 planSold 2.9% of holdings ($1M position)1.3M shares left1x usual sizeFiling
- 3 Form 4 saleRoutineFeb 22 +7 days
Sold 38,548 shares at $0.61 ($24k)
Hibbs Kathy L, Chief Administrative Officer
10b5-1 planSold 3% of holdings ($780k position)1.2M shares left1x usual sizeFiling
- 4 Form 4 saleRoutineMar 7 +14 days
Sold 38,548 shares at $0.53 ($20k)
Hibbs Kathy L, Chief Administrative Officer
10b5-1 planSold 3% of holdings ($684k position)1.3M shares left1x usual sizeFiling
- 5 Form 4 saleRoutineMar 21 +14 days
Sold 38,548 shares at $0.46 ($18k)
Hibbs Kathy L, Chief Administrative Officer
10b5-1 planSold 3% of holdings ($594k position)1.3M shares left1x usual sizeFiling
- 6 Form 4 saleRoutineApr 4 +14 days
Sold 38,548 shares at $0.50 ($19k)
Hibbs Kathy L, Chief Administrative Officer
10b5-1 planSold 3% of holdings ($645k position)1.3M shares left1x usual sizeFiling
- 7 Form 4 saleRoutineApr 18 +14 days
Sold 38,548 shares at $0.47 ($18k)
Hibbs Kathy L, Chief Administrative Officer
10b5-1 planSold 3% of holdings ($607k position)1.3M shares left1x usual sizeFiling
- 8 Form 4 saleRoutineMay 2 +14 days
Sold 38,551 shares at $0.49 ($19k)
Hibbs Kathy L, Chief Administrative Officer
10b5-1 planSold 3% of holdings ($633k position)1.3M shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales, notices and lockups (38)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| May 2, 2024 | Hibbs Kathy L | Chief Administrative Officer | Form 4 sale | 38,551 | $19k | 3.0% | Routine | SEC |
| Apr 18, 2024 | Hibbs Kathy L | Chief Administrative Officer | Form 4 sale | 38,548 | $18k | 3.0% | Routine | SEC |
| Apr 4, 2024 | Hibbs Kathy L | Chief Administrative Officer | Form 4 sale | 38,548 | $19k | 3.0% | Routine | SEC |
| Mar 21, 2024 | Hibbs Kathy L | Chief Administrative Officer | Form 4 sale | 38,548 | $18k | 3.0% | Routine | SEC |
| Mar 7, 2024 | Hibbs Kathy L | Chief Administrative Officer | Form 4 sale | 38,548 | $20k | 3.0% | Routine | SEC |
| Feb 22, 2024 | Hibbs Kathy L | Chief Administrative Officer | Form 4 sale | 38,548 | $24k | 3.0% | Routine | SEC |
| Feb 15, 2024 | Hibbs Kathy L | Chief Administrative Officer | Form 4 sale | 38,548 | $30k | 2.9% | Routine | SEC |
| Jan 25, 2024 | Hibbs Kathy L | Chief Administrative Officer | Form 4 sale | 38,548 | $28k | 2.9% | Routine | SEC |
| Jan 11, 2024 | Hibbs Kathy L | Chief Administrative Officer | Form 4 sale | 38,548 | $28k | 2.9% | Routine | SEC |
| Dec 28, 2023 | Hibbs Kathy L | Chief Administrative Officer | Form 4 sale | 38,548 | $36k | 2.9% | Routine | SEC |
| Dec 14, 2023 | Hibbs Kathy L | Chief Administrative Officer | Form 4 sale | 38,548 | $37k | 2.9% | Routine | SEC |
| Nov 30, 2023 | Hibbs Kathy L | Chief Administrative Officer | Form 4 sale | 38,548 | $34k | 2.9% | Routine | SEC |
| Nov 30, 2023 | Hibbs Kathy L | Officer | Form 144 notice | 269,836 | $242k | Notice | SEC | |
| Nov 16, 2023 | Hibbs Kathy L | Chief Administrative Officer | Form 4 sale | 38,548 | $30k | 2.9% | Routine | SEC |
| Nov 2, 2023 | Hibbs Kathy L | Chief Administrative Officer | Form 4 sale | 38,548 | $34k | 2.9% | Routine | SEC |
| Nov 2, 2023 | Hibbs Kathy L | Officer | Form 144 notice | 77,096 | $63k | Notice | SEC | |
| Oct 19, 2023 | Hibbs Kathy L | Chief Administrative Officer | Form 4 sale | 38,548 | $31k | 2.9% | Routine | SEC |
| Oct 19, 2023 | Hibbs Kathy L | Officer | Form 144 notice | 38,548 | $31k | Notice | SEC | |
| Oct 5, 2023 | Hibbs Kathy L | Chief Administrative Officer | Form 4 sale | 38,548 | $32k | 2.9% | Routine | SEC |
| Oct 5, 2023 | Hibbs Kathy L | Officer | Form 144 notice | 38,548 | $34k | Notice | SEC | |
| Sep 21, 2023 | Hibbs Kathy L | Chief Administrative Officer | Form 4 sale | 38,548 | $39k | 2.9% | Routine | SEC |
| Sep 21, 2023 | Hibbs Kathy L | Officer | Form 144 notice | 38,548 | $38k | Notice | SEC | |
| Sep 7, 2023 | Hibbs Kathy L | Chief Administrative Officer | Form 4 sale | 40,894 | $43k | 13.6% | Routine | SEC |
| Sep 7, 2023 | Hibbs Kathy L | Officer | Form 144 notice | 40,896 | $45k | Notice | SEC | |
| Sep 5, 2023 | Richards William G | Head of Therapeutics Discovery | Form 4 sale | 2,538 | $3k | 1.2% | No plan | SEC |
| Sep 5, 2023 | Richards William G | Officer | Form 144 notice | 2,538 | $3k | Notice | SEC | |
| Aug 24, 2023 | Hibbs Kathy L | Chief Administrative Officer | Form 4 sale | 40,894 | $43k | 13.9% | Routine | SEC |
| Aug 24, 2023 | Hibbs Kathy L | Officer | Form 144 notice | 40,894 | $43k | Notice | SEC | |
| Aug 15, 2023 | Hibbs Kathy L | Chief Administrative Officer | Form 4 sale | 40,894 | $54k | 13.7% | Routine | SEC |
| Jul 27, 2023 | Hibbs Kathy L | Chief Administrative Officer | Form 4 sale | 40,894 | $77k | 13.7% | Routine | SEC |
| Jul 27, 2023 | Hibbs Kathy L | Officer | Form 144 notice | 81,788 | $164k | Notice | SEC | |
| Jul 13, 2023 | Hibbs Kathy L | Chief Administrative Officer | Form 4 sale | 40,894 | $74k | 13.7% | Routine | SEC |
| Jun 29, 2023 | Hibbs Kathy L | Chief Administrative Officer | Form 4 sale | 40,894 | $70k | 13.7% | Routine | SEC |
| Jun 29, 2023 | Hibbs Kathy L | Officer | Form 144 notice | 81,788 | $140k | Notice | SEC | |
| Jun 14, 2023 | Selsavage Joseph Anthony | Officer | Form 144 notice | 24,733 | $49k | Notice | SEC | |
| Dec 5, 2022 | Hibbs Kathy L | Chief Administrative Officer | Form 4 sale | 26,259 | $85k | 10.0% | Plan not stated | SEC |
| Nov 11, 2022 | Scheller Richard H | Director | Form 4 sale | 18,421 | $60k | 20.3% | Plan not stated | SEC |
| Aug 24, 2022 | Hillan Kenneth J. | Chief Therapeutics Officer | Form 4 sale | 8,753 | $32k | 4.3% | Plan not stated | SEC |